Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Sabadell – page 78

3 741 clinical trials in Sabadell, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Sabadell at a glance
3 741
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

3 741 trials in Sabadell

Open in trial search

Migraine

Recruiting

Study on Rimegepant for Preventing Migraines in Children and Teens Aged 6 to 17

Registered drug
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Study of Opevesostat, Olaparib, and Cabazitaxel in Patients with Advanced Prostate Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC

Study on the Safety and Effects of ION440 for Patients with MECP2 Duplication Syndrome

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:ION440
  • Sponsor:Ionis Pharmaceuticals Inc.

Deafness

Recruiting

Study on Long-Term Safety of AAVAnc80-hOTOF Gene Therapy for Patients with Sensorineural Hearing Loss Due to Otoferlin Gene Mutations

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Aavanc80-3'Hotof
  • Sponsor:Akouos Inc.

Acute leukaemia

Recruiting

Study on the Safety and Tolerability of SNDX-5613 for Patients with Relapsed or Refractory Acute Leukemias

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Revumenib
  • Sponsor:Syndax Pharmaceuticals Inc.

Study on Oxytocin and Self-Compassion Training for Patients with Borderline Personality Disorder

Registered drug
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Oxytocin
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

Neoplasm

Recruiting

Study of IMP1734, Paclitaxel, and Abiraterone for Patients with Advanced Solid Tumors

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Eikon Therapeutics Inc.

Study on Post-Operative Chemotherapy with Doxorubicin and Trabectedin for Patients with High-Risk Localized Uterine Leiomyosarcoma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Trabectedin
  • Sponsor:Unicancer

Study on Zanubrutinib and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Fundacion Pethema

Study on Continuous vs. Intermittent Infusion of Ampicillin and Ceftriaxone for Patients with Enterococcus faecalis Infective Endocarditis

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla

Study Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Pfizer Inc.

Crohn's disease

Recruiting

Study of Mirikizumab for Children with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Other cities in Spain

The busiest research cities in the country

All 210 cities in Spain

Clinical research in Sabadell

What the registry says about research in the country

01 Respiratory Medicine

Innovative research focusing on Acute Respiratory Distress Syndrome (ARDS) and advanced lung cancer treatments. Studies evaluating new therapeutic approaches for non-small cell lung cancer, including combination therapies with immunotherapy agents.

  • Mechanical ventilation optimization
  • Combined immunotherapy approaches
  • Advanced stage cancer treatment
02 Oncology Studies

Comprehensive research into various cancer types, including bladder cancer and prostate cancer. Studies examining novel combination therapies and investigating new treatment approaches for both early-stage and metastatic conditions.

  • Immunotherapy combinations
  • Targeted therapies
  • Treatment resistance
03 Autoimmune Conditions

Groundbreaking research in autoimmune disorders including Sjögren's Syndrome and Systemic Sclerosis. Studies evaluating novel biological therapies and investigating long-term treatment outcomes for chronic conditions.

  • Biological therapy assessment
  • Long-term safety evaluation
  • Quality of life improvements
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.